MD. MIRAZUL ISLAM

Mr. MD. MIRAZUL ISLAM

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in BioMed Research International
Verified
Journal Article
Open access
HHHasin Hasnat
Hasin Hasnat
MIMD. MIRAZUL ISLAM
MD. MIRAZUL ISLAM
SSSuriya Akter Shompa
Suriya Akter Shompa
SRSaima Jahan Riti
Saima Jahan Riti
Safaet AlamSafaet Alam
Safaet Alam
MRMohammad Sharifur Rahman
Mohammad Sharifur Rahman
Background: Eichhornia crassipes (water hyacinth) is an invasive aquatic plant traditionally regarded as an environmental nuisance but increasingly recognized for its phytopharmacological potential. Objective: This study is aimed at isolating, characterizing, and evaluating the pharmacological activities of bioactive compounds from the dichloromethane (DCM) fraction of the methanolic extract of E. crassipes flowers. Methods: Compounds were isolated through chromatographic techniques and structurally elucidated using 1 H NMR. Pharmacological activities were assessed using the brine shrimp lethality bioassay for cytotoxicity, egg white–induced edema and human red blood cell membrane stabilization for anti‐inflammatory effects, and oral glucose tolerance tests in mice for hypoglycemic activity. Molecular docking against NF‐ κ B, TNF‐ α , EGFR, BCL‐2, GLUT3, and α ‐amylase, along with ADMET and radar plot analyses, was performed to predict interactions, pharmacokinetics, and drug‐likeness. Results and Discussion: Five compounds were isolated: 4 ′ ,5,7‐trihydroxyflavone or apigenin (Compound 1), 3 ′ ,4 ′ ,5,7‐tetrahydroxyflavone or luteolin (Compound 2), 5,6,7,8,4 ′ ‐pentahydroxyflavone or nortangeretin (Compound 3), methyl 3,5‐dihydroxy‐4‐methoxybenzoate (Compound 4), and 4‐hydroxybenzoic acid (Compound 5). Both the crude methanolic extract (CME) and the DCM‐soluble fraction (DSF) exhibited strong cytotoxic activity in the brine shrimp lethality assay (LC₅₀ < 2 μ g/mL). The DSF further demonstrated potent membrane stabilization (72% protection at 100 μ g/mL) and marked hypoglycemic effects. Also, the CME illustrates dose‐dependent anti‐inflammatory activity in the egg white–induced paw edema model (up to 38.96% inhibition at 600 mg/kg) and showed notable hypoglycemic effects in the oral glucose tolerance test in mice. Docking revealed strong binding affinities of flavonoids with key inflammatory and metabolic targets, outperforming reference drugs in several cases. ADMET profiling indicated favorable oral bioavailability, whereas the BOILED‐Egg model confirmed efficient gastrointestinal absorption but limited blood–brain barrier penetration. Conclusion: This first report of pure compound isolation from E. crassipes flowers highlights their multitarget pharmacological potential. The findings suggest that E. crassipes , often seen as an ecological burden, represents a sustainable reservoir of bioactive molecules with promising drug discovery applications.

8 June 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MIMD. MIRAZUL ISLAM
MD. MIRAZUL ISLAM
SSSuriya Akter Shompa
Suriya Akter Shompa
HHHasin Hasnat
Hasin Hasnat
Safaet AlamSafaet Alam
Safaet Alam
SRSaima Jahan Riti
Saima Jahan Riti
MRMohammad A. Rashid
Mohammad A. Rashid
Eichhornia crassipes (water hyacinth), an invasive aquatic plant, has attracted interest as a potential source of pharmacologically active natural products despite its ecological impact. The present study investigated the petroleum ether soluble fraction (PSF) of the methanolic extract of E. crassipes flowers to identify bioactive constituents and evaluate their biological activities. Chromatographic isolation followed by ¹H NMR spectroscopy led to the identification of five compounds: Kaempferol (Compound 1), Luteolin (Compound 2), Stigmasterol (Compound 3), 4-carboxybenzyl alcohol (Compound 4), and 4-methoxybenzaldehyde (Compound 5). Antimicrobial activity was assessed using disc diffusion and minimum inhibitory concentration (MIC) assays, thrombolytic activity through an in vitro clot lysis method, and antidiarrheal activity using the castor oil–induced diarrhea model in mice. Molecular docking and ADMET analyses were performed to explore potential target interactions and pharmacokinetic characteristics. The PSF exhibited moderate antimicrobial activity, with the highest inhibition against Bacillus subtilis (20.33 ± 1.25 mm) and MIC values ranging from 15.6–500 μL/mL. The extract also produced 14% clot lysis in the thrombolytic assay. In vivo antidiarrheal testing showed dose-dependent inhibition, reaching 38.89% reduction in diarrheal count at 600 mg/kg, approaching the activity of loperamide. Molecular docking analysis revealed that the identified compounds exhibited potential binding affinities comparable to standard ligands, suggesting potential interactions with relevant biological targets. The stigmasterol showing the highest interaction toward the κ-opioid receptor (−10.3 kcal/mol), comparable to loperamide (−9.1 kcal/mol). Flavonoids such as kaempferol and luteolin demonstrated notable binding with antimicrobial targets including dihydrofolate reductase (DHFR) and β-ketoacyl-ACP synthase (KAS), as well as thrombolytic target tissue plasminogen activator (TPA). ADMET predictions indicated favorable drug-likeness for the flavonoids but highlighted lipophilicity-related limitations for stigmasterol. Collectively, these findings highlight the PSF of E. crassipes as a promising reservoir of multi-target phytochemicals with potential applications in gastrointestinal, infectious, and thromboembolic disorders.